Posted on January 5, 20221/5/22
OWP Pharmaceuticals and EVERSANA Announce Partnership to Commercialize Oral Liquid Formulations to Treat Neuroscience Disorders
Posted on December 16, 202112/16/21
EVERSANA Announces Real-World Data Agreement with Janssen to Augment Development of Chronic Disease Care Therapies
Posted on December 13, 202112/13/21
EVERSANA’s Omnichannel Activation Model Named One of The Most Innovative Strategies of 2021 by PM360
Posted on November 23, 202111/23/21
Australian AI Company Artrya Announces Major UK Commercialisation Partnership With EVERSANA
Posted on November 8, 202111/8/21
Q BioMed Bolsters Commercialization of Strontium89 with EVERSANA Partnership
Posted on November 4, 202111/4/21
Membership in European Confederation of Pharmaceutical Entrepreneurs (EUCOPE)
Posted on October 15, 202110/15/21
EVERSANA Acquires Protean; strengthens operational strategy and excellence in market access, channel and patient services
Posted on October 12, 202110/12/21